Cardiovascular Hospitalizations Burden Following Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy
Open Access
- 15 July 2025
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (14) , e040655
Abstract
Background: Longer‐term morbidity post septal myectomy (SM) in obstructive hypertrophic cardiomyopathy has not been well characterized at a national level. We aimed to investigate the nonfatal longer‐term post‐SM outcomes from a national all‐payer individual‐level claims. Methods: The Symphony Health Claims database (2016–2021) was analyzed to identify all adult patients with obstructive hypertrophic cardiomyopathy who underwent SM in the United States and had at least 1 claim within 120 days before SM. The primary outcome was cardiovascular hospitalizations (CVH) starting >30 days post‐SM. Results: A total of 5324 patient (median age 62.0 [52.0–70.0], 53.2% female, 70% commercial insurance) underwent SM and 95.8% were followed >30 days post SM. During 2.7 (1.2–4.2) years median follow‐up, CVH occurred in 46.7% (80% of CVH within 16 months of SM). CVH for new atrial fibrillation/flutter was 25.4%, ventricular arrhythmias 9.7%, syncope 9.3%, myocardial infarction 5.2%, cardiac arrest 1.6%, ventricular septal defect 0.9%, and need for advanced heart failure therapy 0.6%. Repeat SM was required in 43 patients (0.8%). The strongest predictors of CVH post SM were presence of an implantable cardioverter‐defibrillator at baseline (adjusted odds ratio [aOR], 1.72 [95% CI, 1.50–1.97], P P P <0.001). Conclusions: Over a 3‐year period, SM for obstructive hypertrophic cardiomyopathy was associated with a high burden of CVH. Investigating the drivers of these events and strategies to mitigate the high incidence of intermediate and long‐term nonfatal complications post SM will help improve the care of patients with obstructive hypertrophic cardiomyopathy.Keywords
This publication has 26 references indexed in Scilit:
- Impact of concomitant surgical interventions on outcomes of septal myectomy in obstructive hypertrophic cardiomyopathyInternational Journal of Cardiology, 2024
- Ventricular Septal Myectomy Decreases Long-Term Risk for Atrial Fibrillation in Patients With Hypertrophic CardiomyopathyThe American Journal of Cardiology, 2022
- Patient-Reported Atrial Fibrillation After Septal Myectomy for Hypertrophic CardiomyopathyThe Annals of Thoracic Surgery, 2022
- Outcomes Over Follow-up ≥10 Years After Surgical Myectomy for Symptomatic Obstructive Hypertrophic CardiomyopathyThe American Journal of Cardiology, 2022
- Variable selection – A review and recommendations for the practicing statisticianBiometrical Journal, 2018
- Mitral Regurgitation in Patients With Hypertrophic Obstructive CardiomyopathyJACC, 2016
- The Mitral Valve in Obstructive Hypertrophic CardiomyopathyJACC, 2016
- Concomitant Septal Myectomy at the Time of Aortic Valve Replacement for Severe Aortic StenosisThe Annals of Thoracic Surgery, 2010
- Long-Term Effects of Surgical Septal Myectomy on Survival in Patients With Obstructive Hypertrophic CardiomyopathyJACC, 2005
- Clinical Course of Hypertrophic Cardiomyopathy in a Regional United States CohortJAMA, 1999